Found 191 matching trials
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer PHASE2 This study will evaluate the safety and efficacy of inavolisib combination ...
Show More Location
Los Angeles Cancer Network
Learn More & Join Trial
NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer PHASE2 This randomized, parallel cohort, two stage, double-blind, placebo-controll...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial PHASE1 This clinical trial tests the feasibility and utility of a biology guided t...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world N/A SPEAR is a non-interventional / observational, prospective, multicenter stu...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation PHASE2 This is an open-label treatment program following basic prescribing informa...
Show More Location
Greater Baltimore Medical Center
Learn More & Join Trial
Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer PHASE2 This is a phase II, exploratory, open-label, single arm study of BYL719 mon...
Show More Location
Peter MacCallum Cancer Centre
Learn More & Join Trial
Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History NA Philadelphia-negative myeloproliferative neoplasms (MPNs) occur sporadicall...
Show More Location
Multiple Locations
Learn More & Join Trial
Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients PHASE1 The investigator assesses the efficacy and safety of alpelisib and capecita...
Show More Location
Korea University Anam Hospital
Learn More & Join Trial
Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques PHASE2 Open label Phase II study of FOLFIRI + Panitumumab using ultra-selection te...
Show More Location
Spanish Cooperative Group for Digestive Tumour Therapy
Learn More & Join Trial
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831 N/A This research study is looking at tissue samples from women with breast can...
Show More Location
Multiple Locations
Learn More & Join Trial